Dementia and Alzheimer Disease

Negative Effect of Deferiprone Points to Impact of Iron Lowering in Alzheimer Disease

November 21st 2024

The trial, a 20-week study assessing lamotrigine in DLB, will use change in Clinical Dementia Rating-Sum of Boxes as the primary efficacy end point, with several other notable secondary outcomes.

NeuroVoices: Charbel Moussa, PhD, MBBS, on Therapeutic Potential of Nilotinib in Dementia With Lewy Bodies

November 20th 2024

CHMP Gives Positive Opinion for Lecanemab Following Re-Examination of Data

November 20th 2024

NeurologyLive® Friday 5 — November 15, 2024

November 18th 2024

By NeurologyLive® Staff

November 15th 2024

Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis - Current Treatment and Emerging Con...

November 12, 2024

Recognizing Rett Syndrome Early to Improve Long-term Management Outcomes

2024 Neuromuscular Summit

November 20, 2024

5th Annual International Congress on the Future of Neurology®

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

Burst CME: Optimizing Therapy in Parkinson’s Disease

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

Community Practice Connections™: Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis

Burst Expert Illustrations & Commentary™: Visualizing the Role of the Complement Pathway in Neurological Disorders

Individualizing Treatment for Patients with Generalized Myasthenia Gravis

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

Clinical ShowCase™ in ALS: Addressing Diagnostic Delays, Evolving Therapies, and Multidisciplinary Care

Burst Expert Illustrations & Commentary™: Visualizing the Role of FcRN in Neurological Disorders

BURST Expert Illustrations and Commentaries™: Visualizing FcRn as a Therapeutic Target in Neurological Disease

BURST Expert Illustrations and Commentaries™: Visualizing the Implications of FcRN-Targeted Therapies on Generalized Myasthenia Gravis

Clinical Consultations™: Navigating the Evolving Treatment Landscape in Generalized Myasthenia Gravis

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

Burst Expert Illustrations & Commentary™: Visualizing the Role of Subcutaneous Infusion as an Alternate Administration Route for Medical Interventions

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

SimulatEd™ From Discomfort to Relief: Acute Pain Management Essentials

Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

More News

Memory, Thinking Work Better in Complex Jobs

November 26th 2014

Stem Cells Identify Spread of Brain Disorders

Study results suggest that more stimulating work environments may help people retain their cognitive abilities.

November 20th 2014

New Imaging Spots Inflammation in Brain Disorders

The latest scientific developments about the brain and how it works were presented this week at the annual meeting of the Society for Neuroscience. Potential new treatments were identified.

November 18th 2014

HSV Linked to Alzheimer Disease

These findings advance knowledge about the link between brain inflammation and the progression of brain disorders and suggest possible targets for future treatments.

November 5th 2014

Could the common herpes simplex virus be associated with Alzheimer disease? These researchers think it is possible.

Stroke: 5 New Findings

Orexin and Alzheimer: A Link to Impaired Sleep

October 29th 2014

Slideshows

Here: 5 new things to know about stroke -- its link with perioperative A-fib; the danger of cocaine; rehab possibilities with an Alzheimer drug; reducing stroke risk with potassium; and a potential screen for occult A-fib after cryptogenic stroke.

October 21st 2014

Use a Saliva Test to ID Neurodegenerative Disease?

Increased orexin in this disorder is associated with disease severity, total tau protein levels, sleep impairment, and cognitive deterioration.

October 14th 2014

Perhaps the Nose Knows: UPSIT and Alzheimer Disease

Why ask patients to “spit in a cup”? Statistically significant protein differences have been found in Alzheimer disease saliva, and trends have been observed for Parkinson disease.

Anthony H. Risser, PhD

September 12th 2014

Are Alzheimer Biomarkers Clinically Relevant?

Does smell identification have any predictive value for later Alzheimer disease?

September 3rd 2014

Alzheimer Disease: 2 New Studies with Practical Implications

Cerebrospinal fluid biomarker assessment could conceivably become a part of routine clinical practice.

Grace Halsey

August 13th 2014

Study Confirms Vitamin D, Dementia Risk Link

Try to stay current with the flood of published dementia studies these days and you may miss a few with human subjects. Here, a quick review of 2 non-animal analyses that might make you think differently in clinic tomorrow.

August 13th 2014

In Praise of the Amnesia Case Study

The notion that vitamin D deficiency is associated with a substantially increased risk of all-cause dementia and Alzheimer disease was confirmed by the results of the largest study of its kind.

Anthony H. Risser, PhD

July 17th 2014

Coffee: Drink Java for Good Neurologic Health?

As clinicians, we can daily apply knowledge learned from a few patients with pure amnesia to patients we see often-those who have memory deficits, such as so-called Mild Cognitive Impairment and neurodegenerative diseases, such as Alzheimer's.

June 24th 2014

CSF Biomarkers and Alzheimer Disease: Ready for the Clinic?

The remarkable coffee bean is associated with reduced prevalence of several diseases, including Parkinson disease, Alzheimer disease, cancer, cardiovascular disease, and diabetes.

June 18th 2014